Zobrazeno 1 - 10
of 419
pro vyhledávání: '"H. J. G. M."'
Autor:
Beaulieu, J. P., de Wit, W. J., Lamers, H. J. G. M. L., Marquette, J. B., Coutures, C., Leisy, P., Totor, S., Palanque-Delabrouille, N., collaboration, EROS2
Using data from the EROS2 microlensing survey, we report the discovery of two blue objects with irregular photometric behaviour of $\Delta V \sim 0.1$-0.4 mag on time scales of 20 to 200 days. They show a bluer when fainter behaviour. Subsequent spec
Externí odkaz:
http://arxiv.org/abs/astro-ph/0110166
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background and Aims Atrial fibrillation (AF) is the most prevalent arrhythmia, associated with increased mortality and morbidity and causing relevant costs. Treatment options consist of catheter
Autor:
M H J Park Frausing, M Van De Lande, A H Maass, B O Nguyen, M E W Hemels, R Tieleman, T Koldenhof, M De Melis, D Linz, U Schotten, V Weberndorfer, H J G M Crijns, I C Van Gelder, J C Nielsen, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation, and grant support from M
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Purpose To investigate whether there are differences between nondihydropyridine calcium channel blockers and beta blockers on heart rate in patients with paroxysmal and persistent atrial fibrill
Autor:
M E Van De Lande, C Van Deutekom, B Geelhoed, L B O Nguyen, R G Tieleman, V Weberndorfer, H J G M Crijns, M E W Hemels, M De Melis, U Schotten, D Linz, I C Van Gelder, M Rienstra
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): We acknowledge the support from the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foun
Autor:
Svennberg, Emma, Tjong, Fleur, Goette, Andreas, Akoum, Nazem, di Biase, Luigi, Bordachar, Pierre, Boriani, Giuseppe, Burri, Haran, Conte, Giulio, Deharo, Jean Claude, Deneke, Thomas, Drossart, Inga, Duncker, David, Han, Janet K., Heidbuchel, Hein, Jais, Pierre, de Oliveira Figueiredo, Marcio Jansen, Linz, Dominik, Lip, Gregory Y. H., Malaczynska-Rajpold, Katarzyna, Márquez, Manlio F., Ploem, Corrette, Soejima, Kyoko, Stiles, Martin K., Wierda, Eric, Vernooy, Kevin, Leclercq, Christophe, Meyer, Christian, Pisani, Cristiano, Pak, Hui Nam, Gupta, Dhiraj, Pürerfellner, Helmut, Crijns, H. J. G. M., Chavez, Edgar Antezana, Willems, Stephan, Waldmann, Victor, Dekker, Lukas, Wan, Elaine, Kavoor, Pramesh, Turagam, Mohit K., Sinner, Moritz
Publikováno v:
Europace, 25(2). Oxford University Press
In the originally published version of this manuscript, the names of authors Marcio Jansen de Oliveira Figueiredo and Manlio F. Márquez were incorrectly given. Both names have now been corrected online. In addition, the following affiliation was ina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::11d99ccb5a41cf9cff85a4aa7c7a739b
https://pure.amc.nl/en/publications/erratum(a0ddc351-ece7-44d5-ba21-296907947c39).html
https://pure.amc.nl/en/publications/erratum(a0ddc351-ece7-44d5-ba21-296907947c39).html
Autor:
R Van Der Velden, N A H A Pluymaekers, E A M P Dudink, J G L M Luermans, J G Meeder, T Lenderink, J Widdershoven, J J J Bucx, M Rienstra, I C Van Gelder, H J G M Crijns, D Linz
Publikováno v:
European Heart Journal. 43
Introduction Achieving adequate rate control is a mainstay in the treatment of atrial fibrillation (AF). In the Rate Control versus Electrical Cardioversion Trial 7 – Acute Cardioversion versus Wait and See (RACE 7 ACWAS) trial, an early cardiovers
Autor:
A J Camm, H J G M Crijns, A Elvan, Y Tuininga, E Badings, A F M Kuijper, J S S G De Jong, M Lee, D Schellings, I C Van Gelder, J Ruskin, P Kowey, C Dufton, J Maupas, L Belardinelli
Publikováno v:
European Heart Journal. 43
Introduction Pharmacological restoration of sinus rhythm (SR) in patients with symptomatic atrial fibrillation (AF) is expected to be accompanied by prompt alleviation of symptoms to avoid the need for electrical cardioversion (ECV) and/or hospitaliz
Autor:
P Kirchhof, A J Camm, H J G M Crijns, J P Piccini, C Torp-Pedersen, D McKindley, J Stewart, M Wieloch, S H Hohnloser
Publikováno v:
European Heart Journal. 43
Introduction The EAST-AFNET4 study found that early, systematic rhythm control reduced cardiovascular (CV) outcomes in patients with early atrial fibrillation/atrial flutter (AF) of ≤12 months compared to guideline-recommended usual care. Purpose T
Autor:
Nguyen, Bao Oanh, Crijns, Harry J. G. M., Tijssen, Jan G. P., Geelhoed, Bastiaan, Hobbelt, Anne H., Hemels, Martin E. W., Mol, W. J. Myke, Weijs, Bob, Alings, Marco, Smit, Marcelle D., Tieleman, Robert G., Tukkie, Raymond, van Veldhuisen, Dirk J., van Gelder, Isabelle C., Rienstra, Michiel, van Gelder, I. C., Alings, M., Tieleman, R. G., Aksoy, I., Linssen, G. C. M., Bosker, H. A., Verdel, G. J. E., Cramer, E., Crijns, H. J. G. M., Tuininga, Y. S., van der Galiën, A., Hagens, V., de Ruiter, G. S.
Publikováno v:
Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 6, pp. 910-920
Europace, 24(6). Oxford University Press
EP Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 910-920
Europace, 24, 6, pp. 910-920
Europace, 24(6). Oxford University Press
EP Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 910-920
Aims The Routine vs. Aggressive risk factor driven upstream rhythm Control for prevention of Early persistent atrial fibrillation (AF) in heart failure (HF) (RACE 3) trial demonstrated that targeted therapy of underlying conditions improved sinus rhy